Skip to main content
Have a personal or library account? Click to login
Methylphenidate and Desipramine Toxicities Cover

Methylphenidate and Desipramine Toxicities

Open Access
|Sep 1993

Full Article

A double-blind controlled study of medications in 12 children with ADHD at New York University and Stony Brook Schools of Medicine showed that nausea, vomiting, dry mouth, tremor, headache, anorexia, lassitude, and tachycardia occurred more frequently when methylphenidate (20 mg) and desipramine (148 mg/day) were combined in therapy compared to either medication alone. [1]

COMMENT. Behavioral improvements found with tricyclic antidepressants and the positive effects of stimulants on cognitive tasks have prompted combined drug therapy of ADHD. The authors advise larger samples and longer trials before the safety of these drug interactions may be established.

Language: English
Page range: 72 - 72
Published on: Sep 1, 1993
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 1993 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.